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November 20111542 AbstractsVeinMapping Prior to Endovenous Catheter Ablation of Great Saphe-
nous Vein Predicts Risk of Endovenous Heat-Induced Thrombus
Formation
Judith C. Lin, MD, Edward L. Peterson, PhD, Jennifer J. Smith, MD,
Melinda L. Rivera, Mitchell R. Weaver, MD, Division of Vascular Surgery,
Henry Ford Hospital, Detroit, Mich
Objectives: The incidence of endovenous heat-induced thrombus
(EHIT) and deep vein thrombosis (DVT) after endovenous laser treatment
(EVLT) or radiofrequency ablation (VNUS) of truncal vein is low. However,
the consequence may be lethal. We investigate the value of vein mapping prior
to vein ablation for predicting the risk of thrombus formation.
Methods: 355 consecutive vein mappings were prospectively collected
and analyzed. Excluded were 29 patients who did not complete the EVLT or
VNUS procedure. All symptomatic patients underwent venous duplex ul-
trasound to assess for valvular incompetence. Preoperative venous reflux is
defined as0.5 second. Vein mapping of refluxing truncal veins was done at
least the day prior and the diameter of the great saphenous vein (GSV) or
small saphenous vein (SSV) measured. Post-operative duplex were per-
formed between 5-7 days after the procedure. Bivariate analysis of indepen-
dent variables by outcomes was performed using Student’s t-test for contin-
uous variable, chi-square test for categorical variables, and logistic regression
to estimate the odds ratio (OR). Multivariate logistic models were used to
adjust for diameter and refluxing vein.
Results: Among the 355 studies in 330 patients, the average age of the
patients was 55.2 years; 96 male (29.1%) and 231 female (70.9%); 312 were
GSV (95.7%) and 14 SSV (4.3%); 169 right leg (51.4%) and 157 left leg
(48.2%). Among 326 veins, 169 were treated with VNUS (51.8%) and 157
EVLT (48.2%). The immediate post-procedure closure was seen in 319
veins (97.9%). Among the 312 GSV ablation procedures, 10 (3.2%) devel-
oped EHIT or DVT.When comparing the group of patients who developed
EHIT versus no EHIT, the mean GSV diameter was 12.75  5.76 mm
versus 8.5  3.44 mm (OR 1.23, P  .001), the presence of valvular
incompetence at the saphenofemoral junction was 8.33% vs. 0.44% (OR
20.64, p.001), and 3.09% in VNUS vs. 2% in EVLT (OR 0.64, P  .54)
Conclusions: Patients with valvular insufficiency of the saphenofemo-
ral junction and a large proximal GSV diameter had significantly higher risk
of developing heat-induced thrombus formation after endovenous catheter
ablation. There was no difference in the occurrence of EHIT with EVLT or
VNUS procedures in our series.
Bovine Pericardial Patch Repair in Infected Fields
WilliamMcMillan,MD,ChantelHile,MD,ChristopherLeville,MD,Minneapolis
Vascular Physicians, Plymouth,Minn
Objectives: Bovine pericardial patches (BPP) are frequently used for
arterial reconstruction, but little data exists regarding their ability to resist
infection. We hypothesize that BPP would provide a reasonable alternative
to autologous vein patches in infected fields.
Methods:Weused BPP (Synoviousmedical) to repair 51 arteriotomies
(25 brachial, 23 femoral, 3 popliteal) in 48 consecutive patients (mean age
68, 65% men, 75% diabetic, 67% dialysis dependent) undergoing removal of
infected (33 gram positive, 3 gm negative and 8 mixed flora and 4 culture
negative) PTFE grafts ( 35 AV graft, 9 femoral-distal bypass, 4 femoral patch
angioplasty), between 1/2007 and 1/2011. Patients were followed retro-
spectively and outcomes including death, rupture, secondary reconstruction
and infection were recorded.
Results:Over a mean follow up of 2.1 years (range 3-48months) 50 of
51 patches remained in place without evidence of recurrent infection,
rupture or revision. One patient had acute rupture of a popliteal arteriotomy
1 week post repair and had subsequent ligation and above knee amputation.
Eight of the 48 patients died from unrelated causes during follow up. (3
withdrew from dialysis, 3 MI, 2 unkown)
Conclusions: Bovine pericardial patches provide a durable alternative
to saphenous vein for arterial reconstruction following removal of infected
arterial grafts.
Aberrant Subclavian Artery: Presentation and Outcomes
Borzoo Farhang, Nitin Garg, William M. Stone, MD, Joseph J. Ricotta,
MD, Thomas C. Bower, MD, Mayo Clinic, Rochester, Minn
Objectives: Aberrant subclavian artery (ASA) is one of most frequent
aortic arch anomalies. Many authors recommend treatment of symptomatic
or aneurysmal aberrant subclavian arteries, but most of these recommenda-
tions are based on small case series or anecdotal experience. Natural history
of this anomaly is not well defined. Our aim was to review long term
outcomes in patients with this anomaly.
Methods: A retrospective review of all adult patients seen at Mayo Clinic
between1997and2011withadiagnosisofASAwasperformedafter approval from
our institutional review board. Demographic factors and outcome data was col-
lected and analyzed. All patients were diagnosed based on imaging studies.Results: There were 446 patients with diagnosis of Asa and mean age
at diagnosis was 54.7 years (range 1month- 93 years). There were 102berrant left and 344 aberrant right subclavian arteries in 164 male and 284
emale patients. There were more female patients than male with right ASA
2:1) versus similar distribution for left ASA (1.25:1). Forty five (10%)
atients were symptomatic, the most common symptoms being dysphagia
nd/or respiratory. These were presumed from compression, althoughmost
atients noted to have esophageal compression on radiographic study had
o dysphagia. Forty two patients (9.4%) underwent surgical intervention for
SA, all were symptomatic or had aneurysmal degeneration. No patient
resented urgently, except one with acute upper extremity ischemia in
onjunction with aortic and subclavian dissection and underlying right Asa.
ean follow up duration was 6.3 years (range 0-70 years). None of the
atients followed conservatively developed any complications related to the
SA.
Conclusions: Aberrant subclavian artery is a benign anomaly and has
o significant long term consequences. Intervention is recommended in
ymptomatic patients, in whom other causes for symptoms have been ruled
ut. Multiple surgical options should be tailored patient specific problems.
utologous Bone Marrow Mononuclear Cell Therapy Produces Dura-
le Benefits in Limb Salvage at Five Years Post-Treatment
ndrea L. Jester, MD, Raghu L. Motaganahalli, MD, Brian M. Rapp, MD,
eorge A. Akingba, MD, Michael C. Dalsing, MD, Michael G. Wilson,
ndres Fajardo, MD, Michael P. Murphy, MD, Division of Vascular Sur-
ery, IU School of Medicine, Indianapolis, Ind
Objectives: We have previously demonstrated that autologous bone
arrow mononuclear cell (ABMNC) therapy improves measures of limb
erfusion, rest pain, wound healing, and amputation free survival (AFS) at
ne year in patients with critical limb ischemia (CLI). Long term durability
f ABMNC therapy for critical limb ischemia (CLI) remains unknown. The
bjective of this current study is to evaluate long term clinical outcomes five
ears after treatment.
Methods:Data were retrospectively gathered from a database and via a
urvey sent to patients with CLI who had previously underwent intra-
uscular transplantation of ABMNCs in the most symptomatic limb. AFS,
reedom from major amputation, and freedom from major adverse limb
vents (MALE) were calculated using the product-limit estimate. The
ncidence of cardiac, malignant and other medical events during the time
rom treatment to follow-up were tabulated.
Results: Twenty-one of the 24 (87.5%) patients who completed the
nitial one year Phase I trial responded to a detailed questionnaire Interval
rom initial treatment was 188.2 12.3 weeks, range:129- 278). At five
ears AFS was 74% (95% CI, 0.53-0.86; P  .05) (Fig 1), freedom from
ajor amputation was 78% (95% CI, 0.57-0.89; P  .05) (Fig 2) and
reedom fromMALEwas 65 % (95% CI, 0.45- 0.79; P .05) (Fig 3). Three
atients (14.2%) had major cardiac events. There were no incidences of
alignancies or diagnoses of proliferative retinopathy. Fifteen patients
71.4%) report continued improvement in pain-free walking. Nineteen
90.4%) patients felt that the study was of significant medical value and
ould participate again.
Conclusions:ABMNC therapy provides long term freedom fromAFS,
ajor amputation, and MALE that are comparable to surgical and endovas-
ular interventions for CLI. Furthermore this study eliminates the concerns
or tumor genesis and proliferative retinopathy associated with angiogenic
herapies.Fig 1.
